Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8742)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 28, 2016 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li MH, Xie Y, Zhang L, Lu Y, Shen G, Wu SL, Chang M, Mu CQ, Hu LP, Hua WH, Song SJ, Zhang SF, Cheng J, Xu DZ. Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a. World J Hepatol 2016; 8(15): 637-643 [PMID: 27239256 DOI: 10.4254/wjh.v8.i15.637] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i15/637.htm |
| Number | Citing Articles |
| 1 |
Ming-Hui Li, Yao Lu, Lu Zhang, Xing-Yue Wang, Chong-Ping Ran, Hong-Xiao Hao, Dan Zhang, Xiao-Jing Qu, Ge Shen, Shu-Ling Wu, Wei-Hua Cao, Tian-Lin Qi, Ru-Yu Liu, Lei-Ping Hu, Min Chang, Wen-Hao Hua, Shun-Ai Liu, Gang Wan, Yao Xie. Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B. Chinese Medical Journal 2018; 131(15): 1813 doi: 10.4103/0366-6999.237394
|
| 2 |
Hong Li, Xiao Lin, Lili Liu, Ling Qin, Yanhong Zheng, Xiaohui Liu, Xinhuan Wei, Shan Liang, Yali Liu, Jing Zhang, Xinyue Chen, Zhenhuan Cao. Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen Carriers. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.864354
|
| 3 |
W. Zhang, Q. Xie, Q. Ning, X. Dou, X. Chen, J. Jia, Y. Xie, H. Ren. The role of peginterferon in nucleos(t)ide‐analogue‐treated chronic hepatitis B patients: A review of published literature. Journal of Viral Hepatitis 2017; 24(8): 618 doi: 10.1111/jvh.12695
|
| 4 |
Ashish Kumar Vyas, Barjesh Chander Sharma, Shiv Kumar Sarin, Nirupma Trehanpati. Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients. Liver International 2018; 38(1): 38 doi: 10.1111/liv.13475
|
| 5 |
Aixin Song, Xiao Lin, Junfeng Lu, Shan Ren, Zhenhuan Cao, Sujun Zheng, Zhongjie Hu, Hong Li, Chengli Shen, Xinyue Chen. Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.779347
|
| 6 |
Guo-Qing Yin, Ke-Ping Chen, Xiao-Chun Gu. Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment. World Journal of Gastroenterology 2022; 28(40): 5784-5800 doi: 10.3748/wjg.v28.i40.5784
|
| 7 |
Zhenhuan Cao, Sha Meng, Yanhong Zheng, Junli Wang, Rui Wang, Xinyue Chen. Contribution of NK cells to HBsAg seroconversion in inactive HBsAg carriers following pegylated IFN therapy. Innate Immunity 2020; 26(7): 601 doi: 10.1177/1753425920942580
|
| 8 |
Huihui Lu, Wei Yi, Fangfang Sun, Zhan Zeng, Lu Zhang, Minghui Li, Yao Xie. Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy. Biosafety and Health 2021; 3(4): 190 doi: 10.1016/j.bsheal.2021.05.001
|
| 9 |
Qing-Lei Zeng, Zu-Jiang Yu, Jia Shang, Guang-Hua Xu, Chang-Yu Sun, Na Liu, Chun-Xia Li, Jun Lv, Yan-Min Liu, Hong-Xia Liang, Zhi-Qin Li, Ya-Jie Pan, Qiu-Yue Hu, Wei Li, Da-Wei Zhang, Fu-Sheng Wang. Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels. Open Forum Infectious Diseases 2020; 7(6) doi: 10.1093/ofid/ofaa208
|
| 10 |
Wencong Zhang, Mingyou Xing, Wenjin Sun, Jia Chen, Nana Xie, Yuan Cai, Ying Wang, Niuniu Li, Yujin Jiang, Fan Zhang, Yanfeng Wang, Qingjin Zeng, Yanhua Ji, Cheng Xu, Chunmei Jiang, Jianxin Song, Guojun Li. Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real‐world analysis. Journal of Viral Hepatitis 2023; 30(5): 427 doi: 10.1111/jvh.13792
|
| 11 |
Chaojing Wen, Yixuan Wang, Haoyue Tian, Yu Lei, Zhiyi Wang, Dachuan Cai, Zhi Zhou, Xiaofeng Shi. Clinical cure induced by pegylated interferon α-2b in the advantaged population of chronic hepatitis B virus infection: a retrospective cohort study. Frontiers in Cellular and Infection Microbiology 2024; 13 doi: 10.3389/fcimb.2023.1332232
|
| 12 |
Maria Belopolskaya, Viktor Avrutin, Olga Kalinina, Alexander Dmitriev, Denis Gusev. Chronic hepatitis B in pregnant women: Current trends and approaches. World Journal of Gastroenterology 2021; 27(23): 3279-3289 doi: 10.3748/wjg.v27.i23.3279
|
| 13 |
Ming-Hui Li, Lu Zhang, Dan Zhang, Wei-Hua Cao, Tian-Lin Qi, Hong-Xiao Hao, Xing-Yue Wang, Chong-Ping Ran, Xiao-Jing Qu, Shun-Ai Liu, Yao Lu, Ge Shen, Shu-Ling Wu, Min Chang, Ru-Yu Liu, Lei-Ping Hu, Wen-Hao Hua, Gang Wan, Jun Cheng, Yao Xie. Plasmacytoid Dendritic Cell Function and Cytokine Network Profiles in Patients with Acute or Chronic Hepatitis B Virus Infection. Chinese Medical Journal 2018; 131(1): 43 doi: 10.4103/0366-6999.221275
|
| 14 |
Yan Huang, Min Qi, Chengjin Liao, Jinrui Xun, Ju Zou, Haiyue Huang, Li-Yuan Long, Jun Chen, Xuegong Fan, Ruochan Chen. Analysis of the Efficacy and Safety of PEGylated Interferon-α2b Treatment in Inactive Hepatitis B Surface Antigen Carriers. Infectious Diseases and Therapy 2021; 10(4): 2323 doi: 10.1007/s40121-021-00511-w
|
| 15 |
Ming-Hui Li, Lu Zhang, Xiao-Jing Qu, Yao Lu, Ge Shen, Shu-Ling Wu, Min Chang, Ru-Yu Liu, Lei-Ping Hu, Zhen-Zhen Li, Wen-Hao Hua, Shu-Jing Song, Yao Xie. Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment. Chinese Medical Journal 2017; 130(5): 559 doi: 10.4103/0366-6999.200554
|
| 16 |
Ming-Hui Li, Dan Zhang, Lu Zhang, Xiao-Jing Qu, Yao Lu, Ge Shen, Shu-Ling Wu, Min Chang, Ru-Yu Liu, Lei-Ping Hu, Hong-Xiao Hao, Wen-Hao Hua, Shu-Jing Song, Gang Wan, Shun-Ai Liu, Yao Xie. Ratios of T-helper 2 Cells to T-helper 1 Cells and Cytokine Levels in Patients with Hepatitis B. Chinese Medical Journal 2017; 130(15): 1810 doi: 10.4103/0366-6999.211541
|
| 17 |
Yuzhu Dai, Feihu Che, Xiaoxiao Jiang, Dawei Cui, Huajun Zhou, Xujian Xu, Changgui Sun, Jun Cheng. Clinical characteristics and association analysis of persistent low‑level HBsAg expression in a physical examination population with HBV infection. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.8217
|
| 18 |
Huibin Ning, Kuan Li, Zhen Peng, Huiming Jin, Hong Zhao, Jia Shang. The efficacy and safety of pegylated interferon α-2b-based immunotherapy for inactive hepatitis B surface antigen carriers. European Journal of Gastroenterology & Hepatology 2023; 35(10): 1216 doi: 10.1097/MEG.0000000000002627
|
| 19 |
Ming‐hui Li, Qi‐qi Chen, Lu Zhang, Hui‐hui Lu, Fang‐fang Sun, Zhan Zeng, Yao Lu, Wei Yi, Yao Xie. Association of cytokines with hepatitis B virus and its antigen. Journal of Medical Virology 2020; 92(12): 3426 doi: 10.1002/jmv.26301
|
| 20 |
Yan-Jie Lin, Xiao-Yue Bi, Liu Yang, Wen Deng, Ting-Ting Jiang, Ming-Hui Li, Yao Xie. CLINICAL CURE OF A CHRONIC HEPATITIS B PATIENT WITH NORMAL SERUM ALANINE AMINOTRANSFERASE TREATED WITH PEGYLATED INTERFERON ALFA-2A: A CASE REPORT. Gastroenterology Nursing 2023; 46(2): 153 doi: 10.1097/SGA.0000000000000697
|
| 21 |
Henry Lik Yuen Chan. Sequential therapy with antisense oligonucleotide and immune modulator as a strategy for HBV cure. Journal of Hepatology 2024; doi: 10.1016/j.jhep.2024.10.011
|
| 22 |
Zhenhuan Cao, Sha Meng, Yanhong Zheng, Junli Wang, Rui Wang, Xinyue Chen, Isabelle Chemin. B cells were related to HBsAg seroconversion in inactive HBsAg carriers following peginterferon therapy. PLOS ONE 2020; 15(12): e0242559 doi: 10.1371/journal.pone.0242559
|